Well, now that Excellagen has the BPA for 165 VA s
Post# of 36536
(Total Views: 274)
Posted On: 04/02/2020 10:22:37 PM
Well, now that Excellagen has the BPA for 165 VA sites... Generex without question needs to come out with some kind of sales forecast for that product line.
I don’t care if Joe says “that’s what OTC companies do”... any NAZ company would come out with a sales forecast for an approved, money-making, life and limb saving product like this.
And I don’t care if it’s a wide range. They should be able to put together some sort of revenue expectation for Excellagen over the next 12 months... and it should show the world that some real revenues are on the way, even if they only end up hitting the lower end of the range
There is no need to wait on this any longer... it is time to play this card.
I don’t care if Joe says “that’s what OTC companies do”... any NAZ company would come out with a sales forecast for an approved, money-making, life and limb saving product like this.
And I don’t care if it’s a wide range. They should be able to put together some sort of revenue expectation for Excellagen over the next 12 months... and it should show the world that some real revenues are on the way, even if they only end up hitting the lower end of the range
There is no need to wait on this any longer... it is time to play this card.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼